I guess I wouldn't mind knowing if the following order from The US Department of Homeland Security (DHS), that was picked up a while back, will fall into future quarters or was part of the US sales of 30m pounds?? It could easily have slipped into the next quarter given the date I guess. Was the order so huge that no other orders could be delivered during the quarter while GSK stockpiled it? Doesn't sound like it given the wording of the BTA announcement today, or is it BTA have no idea themselves?
"Based on the aforementioned facts and the statutory authority at FAR 6.302-1, the Government intends to award a single non-competitive contract to GlaxoSmithKline (GSK) for this medicine after March 12, 2010."
https://www.fbo.gov/index?s=opportunity&mode=form&id=e1b57d9ab29da69ffefffdb49dacb19e&tab=core&_cview=0&cck=1&au=&ck=
And why was GSK not even tendering for European anti viral tenders?
"Again according to Novinite sources, GlaxoSmithKline did not take part in the tender with the explanation they did not have enough quantities for immediate delivery making Roche the sole possible bidder."
http://www.novinite.com/view_news.php?id=114798
It sounds like a few months wait was not immediate enough?
So many questions and so few answers, but that's life as a BTA share holder sadly.
- Forums
- ASX - By Stock
- BTA
- q1 relenza royalty tipping contest
q1 relenza royalty tipping contest, page-45
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online